Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert CofiledCriticalWarner Lambert Co
Priority to UY27411ApriorityCriticalpatent/UY27411A1/en
Publication of UY27411A1publicationCriticalpatent/UY27411A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se relaciona con compuestos de la fórmula (I) en donde R1, R2 y R3 son lo definido en la memoria descriptiva, su uso como medicamentos, el proceso para su preparación y su uso para el tratamiento de patologías en las cuales la terapia con un inhibidor de PDE4 es relevante.The invention relates to compounds of the formula (I) wherein R1, R2 and R3 are defined in the specification, their use as medicaments, the process for their preparation and their use for the treatment of pathologies in which the therapy With a PDE4 inhibitor it is relevant.
UY27411A2002-08-092002-08-09
1-RENT OR 1-CICLOALQUIL-TRIAZOLO (4, 3-A) QUINAZOLIN-5-ONAS AS PHOSPHODIESTERASE INHIBITORS.
UY27411A1
(en)
compound, pharmaceutical composition, kit, article of manufacture, and methods of inhibiting dpp-iv, therapeutic, and treating a disease state, cancer, autoimmune disorders, a condition and HIV infection
BETA- AMINO TETRAHYDROIMIDAZOL (1,2-A) PIRAZIN AND TETRAHYDROTRIOAZOLO INHIBITORS (4,3-A) PIRAZINAS AS DEPETIDIL PEPTIDASE FOR THE TREATMENT OR PREVENTION OF DIABETES